Di Giacomo AM, Chiarion-Sileni V, Del Vecchio M, Ferrucci PF, et al. Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial. Eur J Cancer 2024;199:113531.
PMID: 38271746